Kuhn W F, Gewirtz D A
Department of Medicine, Medical College of Virginia, Richmond 23298.
Am J Physiol. 1988 May;254(5 Pt 1):G732-40. doi: 10.1152/ajpgi.1988.254.5.G732.
Vasopressin induces alterations in the transmembrane distribution of the bile salts taurocholate and glycocholate but not of cholate, chenodeoxycholate, or chenodeoxycholate derivatives in isolated rat hepatocytes in suspension. Studies were conducted to define the specific transport events modulated by vasopressin. Unidirectional uptake of cholate, taurocholate, and glycocholate, monitored within a 15-s time frame, is not altered by vasopressin. Km values for cholate, taurocholate, and glycocholate influx were found to be 57, 12, and 26 microM, respectively. Vmax values for influx of cholate, taurocholate, and glycocholate were 1.7, 1.8, and 2.4 nmol.mg protein-1.min-1, respectively. At half-maximal effective concentrations, arginine vasopressin increases unidirectional efflux of taurocholate by 34% (EC50 = 1.5 X 10(-9) M) and glycocholate by 17% (EC50 = 5 X 10(-9) M). In the presence of 0.05 microM arginine vasopressin, the apparent Km value for taurocholate efflux decreases from 1.57 mM (control) to 0.94 mM; for glycocholate, the apparent Km decreases from 5.19 mM (control) to 3.22 mM. Vasopressin does not significantly change the Vmax values for taurocholate and glycocholate efflux (0.40 and 1.05 nmol.mg protein-1.min-1, respectively). These studies suggest that modulation of bile salt efflux by vasopressin may be utilized to probe bile salt transport pathways in the rat hepatocyte.
血管加压素可诱导悬浮培养的离体大鼠肝细胞中胆盐牛磺胆酸盐和甘氨胆酸盐的跨膜分布发生改变,但对胆酸盐、鹅去氧胆酸盐或鹅去氧胆酸盐衍生物则无此作用。本研究旨在确定血管加压素调节的特定转运事件。在15秒时间范围内监测到,血管加压素不会改变胆酸盐、牛磺胆酸盐和甘氨胆酸盐的单向摄取。胆酸盐、牛磺胆酸盐和甘氨胆酸盐流入的Km值分别为57、12和26微摩尔。胆酸盐、牛磺胆酸盐和甘氨胆酸盐流入的Vmax值分别为1.7、1.8和2.4纳摩尔·毫克蛋白⁻¹·分钟⁻¹。在半数最大有效浓度时,精氨酸血管加压素可使牛磺胆酸盐的单向流出增加34%(EC50 = 1.5×10⁻⁹摩尔),使甘氨胆酸盐的单向流出增加17%(EC50 = 5×10⁻⁹摩尔)。在存在0.05微摩尔精氨酸血管加压素的情况下,牛磺胆酸盐流出的表观Km值从1.57毫摩尔(对照)降至0.94毫摩尔;对于甘氨胆酸盐,表观Km值从5.19毫摩尔(对照)降至3.22毫摩尔。血管加压素不会显著改变牛磺胆酸盐和甘氨胆酸盐流出的Vmax值(分别为0.40和1.05纳摩尔·毫克蛋白⁻¹·分钟⁻¹)。这些研究表明,血管加压素对胆盐流出的调节作用可用于探究大鼠肝细胞中的胆盐转运途径。